(ACMR) Acm Research - Ratings and Ratios
Wafer,SiC,Chip,Clean,Plating
ACMR EPS (Earnings per Share)
ACMR Revenue
Description: ACMR Acm Research
Acm Research Inc (NASDAQ:ACMR) is a US-based company operating in the Semiconductor Materials & Equipment sub-industry. To understand its financial health, we need to analyze its income tax expense on a yearly basis.
The companys market capitalization stands at approximately $1.55 billion, indicating a mid-cap status. Its price-to-earnings ratio is 14.62, while the forward P/E is 11.89, suggesting potential earnings growth. The return on equity (RoE) is 11.92%, which is a decent metric, indicating the companys ability to generate profits from shareholders equity.
Key economic drivers for ACMR include the demand for semiconductor equipment, driven by the growth of the global semiconductor industry. The companys performance is closely tied to the cyclicality of the semiconductor market, with factors such as chip demand, production capacity, and technological advancements influencing its revenue. To gauge its performance, we can monitor KPIs such as revenue growth rate, gross margin ratio, and operating cash flow margin.
From a trading perspective, ACMRs stock has a beta of 1.354, indicating higher volatility compared to the broader market. Its average trading volume is around 1 million shares, providing sufficient liquidity. To identify potential trading opportunities, we can analyze the stocks price movements in relation to its moving averages (SMA20, SMA50, SMA200) and other technical indicators.
ACMR Stock Overview
| Market Cap in USD | 2,780m |
| Sub-Industry | Semiconductor Materials & Equipment |
| IPO / Inception | 2017-11-03 |
ACMR Stock Ratings
| Growth Rating | 71.2% |
| Fundamental | 65.4% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 77.6% |
| Analyst Rating | 4.33 of 5 |
ACMR Dividends
Currently no dividends paidACMR Growth Ratios
| Growth Correlation 3m | 65.4% |
| Growth Correlation 12m | 81.6% |
| Growth Correlation 5y | -16.6% |
| CAGR 5y | 85.74% |
| CAGR/Max DD 3y (Calmar Ratio) | 1.47 |
| CAGR/Mean DD 3y (Pain Ratio) | 3.74 |
| Sharpe Ratio 12m | 0.63 |
| Alpha | 67.31 |
| Beta | 1.418 |
| Volatility | 78.16% |
| Current Volume | 1376.5k |
| Average Volume 20d | 1789.7k |
| Stop Loss | 37.1 (-6.5%) |
| Signal | 0.14 |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (112.1m TTM) > 0 and > 6% of Revenue (6% = 48.9m TTM) |
| FCFTA -0.01 (>2.0%) and ΔFCFTA 4.22pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 119.6% (prev 109.1%; Δ 10.42pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 60.9m <= Net Income 112.1m (YES >=105%, WARN >=100%) |
| Net Debt (-165.5m) to EBITDA (181.8m) ratio: -0.91 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.45 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (67.5m) change vs 12m ago 0.61% (target <= -2.0% for YES) |
| Gross Margin 49.40% (prev 49.53%; Δ -0.13pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 43.98% (prev 41.59%; Δ 2.39pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 29.59 (EBITDA TTM 181.8m / Interest Expense TTM 5.75m) >= 6 (WARN >= 3) |
Altman Z'' 4.60
| (A) 0.48 = (Total Current Assets 1.65b - Total Current Liabilities 671.0m) / Total Assets 2.04b |
| (B) 0.15 = Retained Earnings (Balance) 310.1m / Total Assets 2.04b |
| (C) 0.09 = EBIT TTM 170.2m / Avg Total Assets 1.85b |
| (D) 0.33 = Book Value of Equity 281.9m / Total Liabilities 848.0m |
| Total Rating: 4.60 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 65.42
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield -0.69% = -0.34 |
| 3. FCF Margin -2.16% = -0.81 |
| 4. Debt/Equity 0.29 = 2.46 |
| 5. Debt/Ebitda -0.91 = 2.50 |
| 6. ROIC - WACC (= 3.86)% = 4.83 |
| 7. RoE 12.03% = 1.00 |
| 8. Rev. Trend 76.55% = 5.74 |
| 9. EPS Trend 10.82% = 0.54 |
What is the price of ACMR shares?
Over the past week, the price has changed by -3.38%, over one month by +28.25%, over three months by +33.78% and over the past year by +103.91%.
Is Acm Research a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ACMR is around 33.93 USD . This means that ACMR is currently overvalued and has a potential downside of -14.49%.
Is ACMR a buy, sell or hold?
- Strong Buy: 4
- Buy: 4
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ACMR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 40.9 | 3% |
| Analysts Target Price | 40.9 | 3% |
| ValueRay Target Price | 38.4 | -3.2% |
Last update: 2025-10-03 13:12
ACMR Fundamental Data Overview
P/E Trailing = 26.0964
P/E Forward = 21.4592
P/S = 3.4107
P/B = 2.8185
Beta = 1.418
Revenue TTM = 815.2m USD
EBIT TTM = 170.2m USD
EBITDA TTM = 181.8m USD
Long Term Debt = 163.0m USD (from longTermDebt, last quarter)
Short Term Debt = 118.9m USD (from shortTermDebt, last quarter)
Debt = 287.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -165.5m USD (from netDebt column, last quarter)
Enterprise Value = 2.56b USD (2.78b + Debt 287.4m - CCE 505.0m)
Interest Coverage Ratio = 29.59 (Ebit TTM 170.2m / Interest Expense TTM 5.75m)
FCF Yield = -0.69% (FCF TTM -17.6m / Enterprise Value 2.56b)
FCF Margin = -2.16% (FCF TTM -17.6m / Revenue TTM 815.2m)
Net Margin = 13.75% (Net Income TTM 112.1m / Revenue TTM 815.2m)
Gross Margin = 49.40% ((Revenue TTM 815.2m - Cost of Revenue TTM 412.5m) / Revenue TTM)
Gross Margin QoQ = 48.50% (prev 47.90%)
Tobins Q-Ratio = 1.26 (Enterprise Value 2.56b / Total Assets 2.04b)
Interest Expense / Debt = 0.61% (Interest Expense 1.76m / Debt 287.4m)
Taxrate = 4.96% (1.89m / 38.2m)
NOPAT = 161.7m (EBIT 170.2m * (1 - 4.96%))
Current Ratio = 2.45 (Total Current Assets 1.65b / Total Current Liabilities 671.0m)
Debt / Equity = 0.29 (Debt 287.4m / totalStockholderEquity, last quarter 986.5m)
Debt / EBITDA = -0.91 (Net Debt -165.5m / EBITDA 181.8m)
Debt / FCF = 9.38 (negative FCF - burning cash) (Net Debt -165.5m / FCF TTM -17.6m)
Total Stockholder Equity = 932.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.50% (Net Income 112.1m / Total Assets 2.04b)
RoE = 12.03% (Net Income TTM 112.1m / Total Stockholder Equity 932.1m)
RoCE = 15.54% (EBIT 170.2m / Capital Employed (Equity 932.1m + L.T.Debt 163.0m))
RoIC = 14.10% (NOPAT 161.7m / Invested Capital 1.15b)
WACC = 10.24% (E(2.78b)/V(3.07b) * Re(11.24%) + D(287.4m)/V(3.07b) * Rd(0.61%) * (1-Tc(0.05)))
Discount Rate = 11.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.17%
Fair Price DCF = unknown (Cash Flow -17.6m)
EPS Correlation: 10.82 | EPS CAGR: -43.47% | SUE: -4.0 | # QB: 0
Revenue Correlation: 76.55 | Revenue CAGR: 18.93% | SUE: -0.56 | # QB: 0
Additional Sources for ACMR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle